文献速递脑血管病认知障碍与痴呆

脑淀粉样血管病相关炎症中自发性ARIA样事件的自然史与治疗结局

Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study.
PubMed 文献 · Neurology · 2021-09-16

这项多中心前瞻性纵向观察研究纳入113例符合CAA-ri诊断标准的住院患者,随访24个月。首次发作后3个月和12个月临床恢复率分别为70.3%和84.1%,影像学恢复率分别为45.1%和77.4%;24个月内复发率38.3%,突然停用静脉大剂量皮质类固醇脉冲治疗较缓慢口服减量者复发风险更高(HR 4.68,95%CI 1.57-13.93,p=0.006)。

要点

  • CAA-ri首次发作后临床和影像学可恢复,但24个月内约38.3%复发。
  • 静脉大剂量皮质类固醇脉冲治疗后应缓慢口服减量,避免突然停药。
  • 基线皮质表面铁沉积者随访中新发脑出血更常见。

核心结论

  • CAA-ri的临床-影像学急性表现具有短暂且可能复发的炎症性特征。
  • 静脉皮质类固醇脉冲治疗后缓慢口服减量可预防复发。
  • β-淀粉样蛋白驱动疾病中自发性ARIA样事件需与治疗相关ARIA鉴别。

研究设计与样本

  • 多中心、基于医院的前瞻性纵向观察性研究,纳入符合CAA-ri诊断标准的住院患者113例。
  • 2013年1月至2017年3月通过Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease βiomarkers International Network招募。
  • 在首次发作及3、6、12、24个月随访时按方案系统收集临床和1.5T MRI数据,MRI由盲法研究者集中判读。

主要发现

  • 113例中确诊CAA-ri 10.6%、很可能71.7%、可能17.7%;平均年龄72.9岁,女性43.4%,APOEε4携带者37.1%,阿尔茨海默病史36.3%,脑出血史33.6%。
  • 基线皮质表面铁沉积者既往脑出血史更常见(52.6% vs 14.3%,p<0.0001),随访中新发脑出血也更常见(19.3% vs 3.6%,p<0.009)。
  • 首次发作后3个月和12个月临床恢复率分别为70.3%(95%CI 61.6%-78.5%)和84.1%(95%CI 76.2%-90.6%),影像学恢复率分别为45.1%(95%CI 36.4%-54.8%)和77.4%(95%CI 67.7%-85.9%)。
  • 首次临床-影像学缓解后24个月内至少1次复发者为38.3%(95%CI 22.9%-59.2%)。
  • 突然停用静脉大剂量皮质类固醇脉冲治疗较缓慢口服减量者复发风险更高(HR 4.68,95%CI 1.57-13.93,p=0.006)。

关键数值与推荐

  • CAA-ri诊断标准:确诊10.6%、很可能71.7%、可能17.7%。
  • 临床恢复:3个月70.3%(95%CI 61.6%-78.5%),12个月84.1%(95%CI 76.2%-90.6%)。
  • 影像学恢复:3个月45.1%(95%CI 36.4%-54.8%),12个月77.4%(95%CI 67.7%-85.9%)。
  • 24个月内复发率38.3%(95%CI 22.9%-59.2%)。
  • 突然停药 vs 缓慢口服减量的复发风险HR 4.68(95%CI 1.57-13.93,p=0.006)。

临床怎么用

  • 对CAA-ri患者应长期随访,监测临床和影像学复发及新发脑出血。
  • 静脉大剂量皮质类固醇脉冲治疗后建议缓慢口服减量,避免突然停药。
  • 对β-淀粉样蛋白驱动疾病中出现自发性ARIA样事件者,需与免疫治疗相关ARIA鉴别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The goal of this work was to investigate the natural history and outcomes after treatment for spontaneous amyloid-related imaging abnormalities (ARIA)-like in cerebral amyloid angiopathy-related inflammation (CAA-ri). METHODS: This was a multicenter, hospital-based, longitudinal, prospective observational study of inpatients meeting CAA-ri diagnostic criteria recruited through the Inflammatory Cerebral Amyloid Angiopathy and Alzheimer's Disease βiomarkers International Network from January 2013 to March 2017. A protocol for systematic data collection at first-ever presentation and at subsequent in-person visits, including T1-weighted, gradient recalled echo-T2*, fluid-suppressed T2-weighted (fluid-attenuated inversion recovery), and T1 postgadolinium contrast-enhanced images acquired on 1.5T MRI, was used at the 3-, 6-, 12-, and 24-month follow-up. Centralized reads of MRIs were performed by investigators blinded to clinical, therapeutic, and time-point information. Main outcomes were survival, clinical and radiologic recovery, intracerebral hemorrhage (ICH), and recurrence of CAA-ri. RESULTS: The study enrolled 113 participants (10.6% definite, 71.7% probable, and 17.7% possible CAA-ri). Their mean age was 72.9 years; 43.4% were female; 37.1% were APOEε4 carriers; 36.3% had a history of Alzheimer disease; and 33.6% had a history of ICH. A history of ICH and the occurrence of new ICH at follow-up were more common in patients with cortical superficial siderosis at baseline (52.6% vs 14.3%, p < 0.0001 and 19.3% vs 3.6%, p < 0.009, respectively). After the first-ever presentation of CAA-ri, 70.3% (95% confidence interval [CI] 61.6%-78.5%) and 84.1% (95% CI 76.2%-90.6%) clinically recovered within 3 and 12 months, followed by radiologic recovery in 45.1% (95% CI 36.4%-54.8%) and 77.4% (95% CI 67.7%-85.9%), respectively. After clinicoradiologic resolution of the first-ever episode, 38.3% (95% CI 22.9%-59.2%) had at least 1 recurrence within the following 24 months. Recurrence was more likely if IV high-dose corticosteroid pulse therapy was suddenly stopped compared to slow oral tapering off (hazard ratio 4.68, 95% CI 1.57-13.93; p = 0.006). DISCUSSION: These results from the largest longitudinal cohort registry of patients with CAA-ri support the transient and potentially relapsing inflammatory nature of the clinical-radiologic acute manifestations of the disease and the effectiveness of slow oral tapering off after IV corticosteroid pulse therapy in preventing recurrences. Our results highlight the importance of differential diagnosis for spontaneous ARIA-like events in β-amyloid-driven diseases, including treatment-related ARIA in patients with Alzheimer disease exposed to immunotherapy drugs.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Antolini L, DiFrancesco JC, Zedde M, et al. Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study. Neurology. 2021. PMID: 34531298. doi:10.1212/WNL.0000000000012778

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。